Fitz Gate Ventures
VC Fund
Houston, United States
Fitz Gate Ventures is a VC fund in Houston focused on Software and Artificial Intelligence. About Fitz Gate Ventures: * Fitz Gate Ventures is an early stage, network-driven venture capital firm formed in 2015 with a focus on the New York and Texas ecosystems where the firm’s principals have deep networks and teach at the Princeton University Graduate School and Rice University Jones School of Business. * The firm brings a unique strategicadvantage to its portfolio companies by leveraging its proprietary “Friends of Fitz” network, comprised of hundreds of venture capitalists, startup founders, educators, senior executives and subject matter experts. * Fitz Gate’s results in Funds I and II are exceptional, and Fitz Gate has recently launched its third fund with a committed anchor investor. * Fitz Gate’s GPs (Jim Cohen and Mark Poag) are mentors to Techstars NYC, the Princeton Entrepreneurship Council, the Rice Alliance, the Rice Lilie Lab and the northeast National Science Foundation I-Corps Hub program, and they are members of Princeton’s Keller Center eLab Advisory Committee and the Princeton Dean for Research’s Advisory Council. Jim and Mark were each awarded the Clio Hall Award in 2022 from the Princeton Graduate School in recognition of their contributions to Princeton’s graduate students. * Fitz Gate writes initial checks of $500K - $2M, reserving for follow-on rounds and has a special focus on deep tech, hard tech, and climate tech. Fitz Gate will lead rounds, co-invest with other funds or invest alone. * World class investors such as Andreessen Horowitz, Sequoia, Bessemer, Canaan, 8VC, Eli Lilly, Temasek/Xora, Blackrock, Greycroft, Spark, Bezos Expeditions, Merck, Fidelity, MIT Engine Fund, Morgan Stanley, Blackstone, First Round, Sapphire, KKR, Fusion Fund, Koch Disruptive Technologies, Fidelity, Liberty Media, Porsche and others have invested in follow-on rounds in Fitz Gate portfolio companies. * To learn more visit www.fitzgate.com
- Total investments:
- 44
- Last investment:
- Lead investor:
- 39%
- Fund size:
- $15M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Fitz Gate Ventures invests in
Stages Fitz Gate Ventures invests in
Countries Fitz Gate Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jim Cohen
|
|||
Lynda Clarizio
|
|||
Mark Poag
|
|||
2 more contacts available
Investment Focus
Industry
- Software 9 (20%)
- Artificial Intelligence 7 (16%)
- Machine Learning 6 (14%)
- Internet 4 (9%)
- Health Care 3 (7%)
Stage
- Seed 16 (36%)
- Series A 10 (23%)
- Series B 4 (9%)
- Pre-Seed 3 (7%)
- Funding Round 1 (2%)
Country
- United States 26 (59%)
- Japan 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jim Cohen
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 4 | Find email | |
|
Lynda Clarizio
Friend of Fitz
|
Friend of Fitz | Total investments: 1 | Find email | |
|
Mark Poag
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Trener Robotics
|
T-robotics uses end-to-end neural networks and constraint-based programming to train AI skills for robots. These skills are directly deployable on all major commercially available robot brands. These skills allow these robots to fail less, perform complex tasks, and program easily. | $32M / Series A / Feb 10, 2026 | |
PATH EX
|
PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood, for the treatment of sepsis. Sepsis, a life-threatening condition that commonly presents itself as a blood-borne infection, is the number one cause of death in the ICU and is the largest cost on their healthcare system. PATH EXis taking a novel approach by capturing and removing intact bacteria from the blood rather than trying to kill the infection with broad spectrum antibiotics. The PATH EX device is effective regardless of bacteria type or drug resistance. The PATH EX technology has the potential to reduce diagnostic times, treatment costs, readmission rates, and sepsis related deaths. | $5M / Venture - Series Unknown / May 08, 2025 | |
Sensetics
|
Sensetics develops tactile sensing and haptic technologies that enable the digital capture and reproduction of touch. Its core product, Touch Signature, is a programmable fabric that integrates soft piezoelectrics and microscale 3D metamaterials to simulate human mechanoreceptors. This technology allows for sub-millimeter resolution touch sensingand haptic feedback, facilitating real-time interaction between users and machines. Sensetics combines this hardware with AI-powered software to analyze and interpret physical contact, supporting applications in remote operations, robotics, and human-machine interfaces. The company's solutions aim to bring touch into the digital realm, enabling bidirectional, interactive experiences between humans and machines. | $1.8M / Pre-Seed / Mar 01, 2025 | |
March Biosciences
|
March Biosciences is a clinical-stage cell therapy company that focuses on developing CAR-T cell strategies to address hematological cancers. | $28.4M / Series A / Oct 23, 2024 | |
Quantum Circuits
|
Quantum Circuits, Inc. (QCI) is a private venture founded in late 2015. QCI’s long-term goal is to develop, manufacture, and sell the first practical and useful quantum computers based on superconducting devices. Along the way to building a quantum computer, QCI will commercialize the components, devices, and software that will accelerate basicresearch and enable the scaling of quantum computing.“Quantum circuits” has a double meaning. First, the name indicates that QCI is focusing on the quantum circuit model for quantum computation, which enables universal and fault-tolerant operations using error correction. Second, our technology relies on quantum circuits – electrical devices using superconducting Josephson junctions that can act as solid-state quantum bits, or qubits.QCI was founded by three scientists from the Department of Applied Physics at Yale University: Michel Devoret, Luigi Frunzio, and Robert Schoelkopf. They are world-leading experts in quantum devices and quantum information processing with solid-state devices, with a decades-long record of innovation in new devices, techniques, and fundamental concepts. Their group has produced many scientific firsts, including the development of a “quantum bus” for entangling qubits with wires, the first implementation of a quantum algorithm with a solid-state device, and the demonstration of solid-state qubits with scalable levels of coherence. | $60M / Series B / May 01, 2024 | |
DetraPel
|
DetraPel is a cleantech Advanced Materials company specializing in synthesizing & manufacturing PFAS-Free Protective Coatings. | $7.6M / Series A / Sep 11, 2023 | |
|
Pixical
|
Marketplace for extra-curricular activities | Seed / Dec 06, 2022 | |
|
DetraPel
|
DetraPel is a cleantech Advanced Materials company specializing in synthesizing & manufacturing PFAS-Free Protective Coatings. | $5.3M / Series A / Nov 07, 2022 | |
Spruce
|
Spruce develops a platform that enables individuals to receive services in their homes through a mobile app. Its services range from full housekeeping to a quick tidy up or a dog walk for a furry friend. The company was founded in 2016 and is headquartered in Austin, Texas. | $26M / Series B / Jul 19, 2022 | |
Realworld
|
Realworld simplifies and automates the complexities of adulthood -- finance, health, insurance, and more, all in one place. | $3.2M / Seed / Jun 07, 2022 | |
| See all 44 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Fitz Gate Ventures invest in?
Fitz Gate Ventures invests primarily in Software, Artificial Intelligence and Machine Learning startups, most often at Seed and Series A stage. Most of the 44 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Fitz Gate Ventures?
Public channels for Fitz Gate Ventures include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fitz Gate Ventures?
The team at Fitz Gate Ventures includes Jim Cohen (Co-Founder and General Partner), Lynda Clarizio (Friend of Fitz) and Mark Poag (Co-Founder and General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
